We are live on ! Find out more
ACERW

Acer Therapeutics Inc Warrant

Delisted

ACERW was delisted on the 5th of April, 2018.

4 hedge funds and large institutions have $6K invested in Acer Therapeutics Inc Warrant in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 54 (-1)

40% less capital invested

Capital invested by funds: $10K → $6K (-$4K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$3K +$7.91K +1,001,125 New
RPGK
2
Retirement Planning Group (Kansas)
Kansas
$2K
Bank of New York Mellon
3
Bank of New York Mellon
New York
$1K -$317 -40,153 -12%
California Public Employees Retirement System
4
California Public Employees Retirement System
California
-$3K -266,050 Closed
TSS
5
Two Sigma Securities
New York
-$678 -85,810 -61%
VF
6
Virtu Financial
New York
-$1K -47,466 Closed
UBS Group
7
UBS Group
Switzerland
+$251 +31,793 +464%

ACERW Hedge Fund Activity: Q1 2018 in Review

4 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc Warrant (ACERW) for Q1 2018, worth a combined $6K — down 40% from $10K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ACERW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $7.91K. The largest seller was California Public Employees Retirement System, exiting entirely with an estimated $3K sold.

  • 4 institutional investors held Acer Therapeutics Inc Warrant (ACERW) as of Q1 2018, down from 5 in Q4 2017.
  • Funds reported $6K of Acer Therapeutics Inc Warrant stock for Q1 2018, down 40% quarter-over-quarter.
  • 1 fund opened new Acer Therapeutics Inc Warrant positions in Q1 2018 and 2 closed out, a net change of -1 holder.
  • The largest Acer Therapeutics Inc Warrant buyer in Q1 2018 was Susquehanna International Group, an estimated $7.91K added.
  • The largest Acer Therapeutics Inc Warrant seller in Q1 2018 was California Public Employees Retirement System, an estimated $3K sold.

Based on aggregated 13F filings for Q1 2018.